SS

Sudhir Sharma

Active Director Director DIN 03424678
DIN 03424678 First appointment Jan 2011 Primary industry Real Estate and Construction
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jan 2011
Shareholding value •••• Premium profile

About Sudhir Sharma

Data last updated:

Sudhir Sharma is a Director at Evroy Infraventures Private Limited (since 2013), Director at Tyco Hospitals Private Limited (since 2011) and Director at Shri K L Shahstri Hospitality Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Real Estate and Construction, Healthcare and Travel and Hospitality. The 3 current companies with reported revenue have a combined latest revenue of ₹17.06 Cr; the largest is Evroy Infraventures Private Limited at ₹11.66 Cr (FY 2025). Earlier, Sudhir Sharma was a Director at Altis Institute Of Medical Science Private Limited (from 2016).

DIN 03424678
Primary Designation Director
Industry Real Estate and Construction
First Appointment 09 Jan 2011
Oldest Company Age 23 yrs
Largest company Evroy Infraventures Private Limited · ₹11.66 Cr (FY 2025)
Combined revenue ₹17.06 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Evroy Infraventures Private Limited U45400UP2013PTC057981
Director26 Jun 20132013₹11.66 Cr (FY 2025)Active
Tyco Hospitals Private Limited U85110UP2003PTC027515
Director09 Jan 20112003₹5.40 Cr (FY 2025)Active
Director19 Jul 20232023₹4,438 (FY 2025)Active
Evroy Agro Llp AAE-5194
Designated Partner05 Aug 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Apr 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Evroy Infraventures Private Limited
Altis Institute Of Medical Science Private Limited
Tyco Hospitals Private Limited
Evroy Agro Llp
Premium access

Shareholding and investment profile for Sudhir Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhir Sharma

Sudhir Sharma currently holds 4 directorships: Evroy Infraventures Private Limited (Director, since 26 Jun 2013, revenue ₹11.66 Cr (FY 2025)); Tyco Hospitals Private Limited (Director, since 09 Jan 2011, revenue ₹5.40 Cr (FY 2025)); Shri K L Shahstri Hospitality Private Limited (Director, since 19 Jul 2023, revenue ₹4,438 (FY 2025)); Evroy Agro Llp (Designated Partner, since 05 Aug 2015).

Sudhir Sharma was first appointed on 09 Jan 2011 as Director at Tyco Hospitals Private Limited. The most recent appointment on record is 19 Jul 2023 at Shri K L Shahstri Hospitality Private Limited.

The 3 current companies of Sudhir Sharma that report revenue have a combined latest revenue of ₹17.06 Cr: Evroy Infraventures Private Limited ₹11.66 Cr (FY 2025); Tyco Hospitals Private Limited ₹5.40 Cr (FY 2025); Shri K L Shahstri Hospitality Private Limited ₹4,438 (FY 2025).

Sudhir Sharma held 1 earlier board appointment: Altis Institute Of Medical Science Private Limited (Director, from 29 Apr 2016).

The current boards of Sudhir Sharma's companies include Ankit Dhamija (Evroy Infraventures Private Limited), Vineet Sharma (Evroy Infraventures Private Limited), Ajay Gaurav Sharma (Tyco Hospitals Private Limited), Bandana Sharma (Tyco Hospitals Private Limited), Usha Sharma (Tyco Hospitals Private Limited), Bharti Parashar (Shri K L Shahstri Hospitality Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available